TRIMZED 35

MRP

165/Strip

Description

• Each Film Coated Modified Release Tablet Contains: Trimetazidine Dihydrochloride IP 35 mg

Doses

• As Directed by Physician

Indication

Trimetazidine is an anti-ischemic (anti-anginal) metabolic agent, which improves myocardial glucose utilization through inhibition of fatty acid metabolism, also known as fatty acid oxidation inhibitor